PDE4A and Cognitive impairment: Additionally, PDE4 inhibition has been shown to reduce microglial activation and inflammatory factor release, thereby attenuating neuroinflammation [45], findings that are consistent with our observations in the chronic plateau cognitive impairment study presented here.